Vishal Doshi – AUM Biosciences, AI and the Cure for Cancer
In a world infatuated by the latest shiny technology it’s easy to lose sight of the key challenges facing our time – like finding a cure for cancer.
The drug discovery process is both expensive and by nature highly wasteful. Less than 5% of drugs under development ever reach the mass market. But that doesn’t mean the 95% are not worthy of public consumption, it just means the economics didn’t make sense for larger pharmaceuticals. AUM Biosciences wants to change that. By applying AI and Big Data technology to the extensive data sets generated by pharmaceutical companies, AUM hopes to sift through the drugs that didn’t make the mass market and revisit those that could work under different conditions. Could this mean access to cheaper drugs? Could this mean we also see Asia driving drug discovery and innovation in the future?